{"organizations": [], "uuid": "5e89f46df46e1ce9930a8dcc29568fba07f2212b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180426.html", "section_title": "Archive News &amp; Video for Thursday, 26 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-west-announces-q1-earnings-per-sha/brief-west-announces-q1-earnings-per-share-0-58-idUSASC09XLU", "country": "US", "domain_rank": 408, "title": "West Announces Q1 Earnings Per Share $0.58", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-26T18:15:00.000+03:00", "replies_count": 0, "uuid": "5e89f46df46e1ce9930a8dcc29568fba07f2212b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-west-announces-q1-earnings-per-sha/brief-west-announces-q1-earnings-per-share-0-58-idUSASC09XLU", "ord_in_thread": 0, "title": "West Announces Q1 Earnings Per Share $0.58", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "west pharmaceutical services inc", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 26 (Reuters) - West Pharmaceutical Services Inc :\n* WEST ANNOUNCES FIRST-QUARTER 2018 RESULTS\n* SEES FY 2018 SALES $1.72 BILLION TO $1.73 BILLION * Q1 SALES $415.7 MILLION VERSUS I/B/E/S VIEW $404.2 MILLION\n* Q1 EARNINGS PER SHARE VIEW $0.64 — THOMSON REUTERS I/B/E/S\n* Q1 ADJUSTED EARNINGS PER SHARE $0.62 EXCLUDING ITEMS * REAFFIRMED FINANCIAL GUIDANCE FOR FULL-YEAR 2018\n* FY2018 EARNINGS PER SHARE VIEW $2.82, REVENUE VIEW $1.72 BILLION — THOMSON REUTERS I/B/E/S\n* ESTIMATES ITS 2018 CAPITAL SPENDING WILL BE LESS THAN $150 MILLION\n* WEST PHARMACEUTICAL SERVICES - CUMULATIVE EFFECT OF NEW ACCOUNTING RULES HAD IMMATERIAL NEGATIVE IMPACT TO Q1 2018 NET SALES OF $3 MILLION Source text for Eikon:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-26T18:15:00.000+03:00", "crawled": "2018-04-27T16:19:14.000+03:00", "highlightTitle": ""}